Scientists at the Gladstone Institutes have discovered that an FDA-approved anti-epileptic drug reverses memory loss and alleviates other Alzheimer's-related impairments in an animal model of the disease.
Aug 6, 2012
1
2
An existing anti-seizure drug improves memory and brain function in adults with a form of cognitive impairment that often leads to full-blown Alzheimer's disease, a Johns Hopkins University study has found.
Jul 20, 2011
0
1
Researchers from an Indiana University School of Medicine-led consortium of Alzheimer's disease experts are studying how an anti-seizure drug used to treat epilepsy in children and adults could be repurposed as a potential ...
Nov 30, 2022
0
4
(HealthDay)—For children aged 4 to 13 years with epilepsy, initiating oxcarbazepine, but not levetiracetam, antiseizure medication (ASM) is associated with an increased risk for nontrauma fracture, according to a study ...
Sep 22, 2021
0
33
A new study published in The Lancet, involving researchers from the University of Liverpool and Alder Hey Children's Hospital Trust, has identified a 'user friendly' treatment for the most common life-threatening neurological ...
May 7, 2019
0
4
(HealthDay)—Antiepileptic drug (AED) use is not significantly associated with dementia risk in patients in Germany, according to a study published online March 12 in the Journal of Alzheimer's Disease.
Mar 21, 2019
0
7
(HealthDay)—Levetiracetam performs better than carbamazepine and lamotrigine for individuals with partial seizures, according to a review and meta-analysis published online June 29 in the Cochrane Library.
Aug 2, 2017
0
0
A new study finds that the epilepsy drug levetiracetam appears not to be associated with thinking, movement and language problems for preschool children born to mothers who took the drug during pregnancy, although the drug ...
Jan 8, 2014
0
0
A brain study in infant rats demonstrates that the anti-epilepsy drug phenobarbital stunts neuronal growth, which could prompt new questions about using the first-line drug to treat epilepsy in human newborns.
May 11, 2012
0
0
Michigan State University researchers, with the help of a groundbreaking medical device, are starting a clinical trial in Africa they hope will provide relief for the hundreds of thousands of children who survive cerebral ...
May 1, 2012
0
0
Levetiracetam (INN) ( /lɛvɨtɪˈræsɨtæm/) is an anticonvulsant medication used to treat epilepsy. It is the S-enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam.
Levetiracetam is marketed under the trade name Keppra. Keppra is manufactured by UCB Pharmaceuticals Inc. Since November of 2008 the drug has been available as a generic brand in the United States.
This text uses material from Wikipedia, licensed under CC BY-SA
